Madeline Schaeffer, DO
NPI 1295268282 · Dermatology Physician · Franklin, WI
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1295268282
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- DO
- Sex
- Female
- Sole proprietor
- Yes
- License
- 77234-21 (WI)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
9 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
1,038 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 397 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 165 | $87 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 107 | $46 |
| Biopsy of Related Skin Growth, First Growth11102 | 88 | $84 |
| Destruction of Skin Growth, 1-14 Growths17110 | 80 | $105 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 160 | 115 |
| Clobetasol Propionate | 130 | 76 |
| Ketoconazole | 71 | 42 |
| Hydrocortisone | 38 | 33 |
| Doxycycline Monohydrate | 31 | 21 |
| Mupirocin | 28 | 19 |
| Metronidazole | 24 | 19 |
| Fluconazole | 20 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$4,639 across 284 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 16455 W Bluemound Rd Ste 120Brookfield, WI 53005-5921Phone: (262) 784-7820Fax: (262) 784-7936
- 2600 N Mayfair Rd Ste 810Milwaukee, WI 53226-1328Phone: (414) 771-1122Fax: (414) 771-1352
Registry dates
- Enumerated
- 2017-04-06
- Last updated
- 2025-11-21
- Certified
- 2025-11-21
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.